Medication Description: Testobromycite (Testobromlecithum)
White coated tablets with a yellowish tinge, containing methyltestosterone 0.005 g, bromized 0.1 g and lecithin 0.05 g.
The main active ingredient is methyltestosterone, which has androgenic and low anabolic activity; bromized and lecithin have a calming effect on the central nervous system and improve metabolic processes.
Applied in men with autonomic nervous disorders associated with insufficiency of the function of the sex glands, with menopausal syndrome, neurasthenia, fatigue, neurotic forms of angina, etc.
Women are prescribed for menopausal syndrome or after surgery for cancer of the ovaries, uterus, as well as for functional uterine bleeding.
Accept sublingually or inside. In the first few days, 1 to 2 tablets are prescribed to men for 3 times a day, then 1 tablet 2 to 3 times a day. The course of treatment lasts 1 - 2 months; if necessary, repeat the treatment after a 3 - 4 - month break.
For women with functional bleeding in the premenopausal period, 2 to 4 tablets per day are prescribed for 2 to 4 weeks; at the phenomena of pathological menopause - 1 tablet 1 time per day until the termination of pathological disorders.
The drug is contraindicated in lesions of the liver, adenoma and prostate cancer.
Form release: pills in a package of 25 pieces.
Storage: List B. In a dry, dark place.
Rp: Tab. <Testobromlecithum> obd.